|
How Biotech Can Succeed Outside the Hubs | Inc
Though most biopharma investments are in two states, follow this model to bring the research—and investments—elsewhere.
NIH funding uncertainty spurs new biotech venture fund | TechCrunch
Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to research institutions.
Biotech’s legal storm: Why securities class action lawsuits are surging | LABiotech
The biotech industry faces legal challenges. In 2024, despite resilient performance, there has been a sharp rise in class action lawsuits against biotech and medtech firms.
FDA's diversity guidance now comes with warning from White House | Fierce Biotech
While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a message from the Trump administration that the guidance “does not reflect biological reality.”
Trump Firings Throw Medtech into Regulatory Uncertainty | MDDI
Mass layoffs at HHS, including deep cuts at FDA, spark concerns over regulatory hurdles for the medtech industry.
Stryker completes acquisition of Inari Medical | MassDevice
Stryker announced today that it completed its previously announced acquisition of Inari Medical. The Portage, Michigan-based orthopedic giant announced last month that it struck a deal to acquire Inari worth $4.9 billion
U.S. investors, Big Pharma race to find new medicines in China | CNBC
U.S. investors like Bain and large pharmaceutical companies like Merck are increasingly looking for new medicines in China.
Medtech firms have little to say on Trump tariffs | MedTechDive
Wall Street analysts said current tariffs should be “manageable” for the sector but cautioned that other countries may retaliate.
Fat, not muscle: drugmakers in race for next weight-loss breakthrough | Reuters
Current weight-loss methods, such as lifestyle changes, surgery, and therapies like Wegovy and Zepbound, lead to fat and muscle loss, raising fall risks and decreasing strength, particularly in older patients.
| 
